Patient presents with progressive cognitive decline consistent with a diagnosis of Senile Degeneration of the Brain, now more commonly referred to as Alzheimer's disease.  Symptoms include gradual memory loss, particularly short-term memory deficits, impacting activities of daily living.  The patient exhibits difficulty with word-finding (anomia) and language comprehension, contributing to impaired communication.  Disorientation to time and place is noted, along with challenges in executive function, including planning and problem-solving.  Behavioral changes such as apathy, social withdrawal, and mood fluctuations have been observed.  The patient's medical history is significant for hypertension and hyperlipidemia, both managed medically. Family history is positive for dementia.  Neurological examination reveals no focal neurological deficits.  Mini-Mental State Examination (MMSE) score indicates moderate cognitive impairment.  Differential diagnoses considered included vascular dementia, Lewy body dementia, and frontotemporal dementia.  Based on the clinical presentation, cognitive assessment, and absence of other neurological findings, the diagnosis of Alzheimer's disease is most likely.  A treatment plan focused on symptomatic management and disease modification has been initiated, including cholinesterase inhibitors for cognitive symptoms and non-pharmacological interventions such as cognitive stimulation therapy.  Caregiver education and support have been provided, addressing safety concerns and strategies for managing behavioral changes.  Prognosis and potential disease progression were discussed with the patient and family. Follow-up appointments are scheduled for monitoring disease progression and adjusting treatment as needed.  ICD-10 code G30.9 Alzheimer's disease, unspecified, has been assigned.